Study Evaluating ISM5411 Administered Orally to Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 8, 2023

Primary Completion Date

September 4, 2024

Study Completion Date

September 4, 2024

Conditions

Healthy Subjects

Interventions

DRUG

ISM5411

Investigational Drug

DRUG

Placebo

ISM5411 Matching Placebo

Trial Locations (1)

Nucleus Network, Melbourne

All Listed Sponsors

lead

InSilico Medicine Hong Kong Limited

INDUSTRY

NCT06012578 - Study Evaluating ISM5411 Administered Orally to Healthy Volunteers | Biotech Hunter | Biotech Hunter